EMERGENT BIOSOLUTIONS INC. — Revenue by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/de4eb2b8-695f-44d2-b130-d4cf2563a8a9/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $742.9M | 2025-01-01 – 2025-12-31 | evidence 0001367644-26-000015 |
| FY 2024 | $1.0B | 2024-01-01 – 2024-12-31 | evidence 0001367644-26-000015 |
| FY 2023 | $1.0B | 2023-01-01 – 2023-12-31 | evidence 0001367644-26-000015 |
| FY 2022 | $1.1B | 2022-01-01 – 2022-12-31 | evidence 0001367644-23-000207 |
| FY 2021 | $1.8B | 2021-01-01 – 2021-12-31 | evidence 0001367644-23-000207 |
| FY 2020 | $1.6B | 2020-01-01 – 2020-12-31 | evidence 0001367644-23-000207 |
| FY 2019 | $1.1B | 2019-01-01 – 2019-12-31 | evidence 0001367644-22-000024 |
| FY 2018 | $117.8M | 2018-01-01 – 2018-12-31 | evidence 0001367644-19-000023 |
| FY 2017 | $560.9M | 2017-01-01 – 2017-12-31 | evidence 0001367644-19-000016 |
| FY 2016 | $488.8M | 2016-01-01 – 2016-12-31 | evidence 0001367644-19-000016 |
| FY 2015 | $489.3M | 2015-01-01 – 2015-12-31 | evidence 0001367644-17-000014 |
| FY 2014 | $404.5M | 2014-01-01 – 2014-12-31 | evidence 0001367644-17-000014 |
| FY 2013 | $312.7M | 2013-01-01 – 2013-12-31 | evidence 0001367644-14-000016 |
| FY 2012 | $281.9M | 2012-01-01 – 2012-12-31 | evidence 0001367644-13-000016 |
| FY 2011 | $273.4M | 2011-01-01 – 2011-12-31 | evidence 0001367644-12-000012 |
| FY 2010 | $286.2M | 2010-01-01 – 2010-12-31 | evidence 0001367644-12-000012 |
| FY 2009 | $234.8M | 2009-01-01 – 2009-12-31 | evidence 0001367644-12-000012 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
EMERGENT BIOSOLUTIONS INC. — all facts · Net Income · Operating Income